Polymyalgia Rheumatica: Diagnosis and Diagnostic Tests
Polymyalgia rheumatica (PMR) is an inflammatory rheumatic disease affecting adults over 50 years of age, characterized by bilateral pain and stiffness in the shoulder girdle, neck, and pelvic girdle with elevated inflammatory markers and rapid response to glucocorticoid therapy. 1, 2
Clinical Characteristics
- PMR is the second most common inflammatory rheumatic condition in older adults after rheumatoid arthritis 1
- Typical presentation includes:
- Systemic inflammatory response is present in most cases 1
Diagnostic Approach
Laboratory Tests
- Elevated inflammatory markers:
- Note: High levels of inflammatory markers at diagnosis may influence disease outcomes 5
Imaging Studies
- Musculoskeletal ultrasound is increasingly used in PMR evaluation 6
- Other imaging modalities may be used to exclude alternative diagnoses 2
Classification Criteria
- In 2012, the European League Against Rheumatism (EULAR) and American College of Rheumatology (ACR) developed provisional classification criteria for PMR 4
- These criteria include:
Differential Diagnosis
- Several conditions can mimic PMR and must be excluded:
Therapeutic Response as Diagnostic Test
- A rapid response to low-dose glucocorticoids (15-20 mg prednisone equivalent daily) is considered a diagnostic feature 3
- Lack of response should prompt reconsideration of the diagnosis 2, 3
Common Pitfalls in Diagnosis
- Failure to exclude other conditions that can mimic PMR 2
- Over-reliance on inflammatory markers alone (they may be normal in some cases) 4
- Not considering associated conditions like giant cell arteritis 1
- Inadequate follow-up to confirm diagnosis through treatment response 3